Financial Counselors Inc. Purchases New Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Financial Counselors Inc. purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 375 shares of the biotechnology company’s stock, valued at approximately $223,000.

Several other hedge funds have also bought and sold shares of AXON. The Manufacturers Life Insurance Company boosted its holdings in Axon Enterprise by 0.6% during the third quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock worth $17,440,000 after buying an additional 276 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $84,000. Brooklyn Investment Group purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at about $41,000. Townsquare Capital LLC acquired a new position in Axon Enterprise in the 3rd quarter worth about $261,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Axon Enterprise by 13.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 50,492 shares of the biotechnology company’s stock worth $20,177,000 after purchasing an additional 5,834 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 2.9 %

AXON opened at $534.95 on Friday. The firm has a market capitalization of $40.99 billion, a price-to-earnings ratio of 138.23, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company’s 50 day simple moving average is $589.62 and its two-hundred day simple moving average is $549.29. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Analyst Ratings Changes

Several brokerages have recently weighed in on AXON. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Robert W. Baird upped their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Finally, Barclays reiterated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.